Not applicableStudy completedNCT00216749What this trial is testingEfficacy and Safety of Cilostazol for the Indication of CSPSWho this might be right forCerebral Infarction Korea Otsuka Pharmaceutical Co., Ltd. 650
Not applicableUnknownNCT05757635What this trial is testingA Research of Application of the New Model of Standardized Secondary Prevention of StrokeWho this might be right forAcute Ischemic Stroke Peking Union Medical College Hospital 5,000
Not applicableStudy completedNCT03153020What this trial is testingDeterminants of Adherence to Post-stroke/Transient Ischemic Attack Secondary Prevention Treatment: Cohort Study in the RhôneWho this might be right forStrokeTransient Ischemic Attack Hospices Civils de Lyon 633
Not applicableStudy completedNCT04233515What this trial is testingUse of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro CountyWho this might be right forAtrial FibrillationStroke, Ischemic Region Örebro County 11,964
Testing effectiveness (Phase 2)Study completedNCT00885456What this trial is testingProgram of Rehabilitative Exercise and Education to Avert Vascular Events After Non-disabling Stroke or Transient Ischemic Attack: A Multi-site RCTWho this might be right forTransient Ischemic AttackNon-disabling Stroke Marilyn MacKay-Lyons 187
Not applicableStudy completedNCT02238470What this trial is testingIntracerebral Hemorrhage Due to Oral Anticoagulants: Prediction of the Risk by Magnetic ResonanceWho this might be right forIschemic Stroke Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,000
Post-approval studies (Phase 4)Study completedNCT00077805What this trial is testingPREVAIL: PREvention of VTE After Acute Ischemic Stroke With LMWH Enoxaparin ( - VTE: Venous Thromboembolism - LMWH: Low Molecular Weight Heparin)Who this might be right forAcute Ischemic Stroke Sanofi
Post-approval studies (Phase 4)Looking for participantsNCT04974151What this trial is testingChina Stroke Primary Prevention Trial 2 for Participants With Hypertension and MTHFR 677 TT GenotypeWho this might be right forHypertensionMTHFR 677 TT Genotype Shenzhen Ausa Pharmed Co.,Ltd 24,000
Post-approval studies (Phase 4)Looking for participantsNCT05995600What this trial is testingComparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin As Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKEWho this might be right forAntiphospholipid SyndromeIschemic StrokeTransient Ischemic Attack+3 more Seoul National University Hospital 200
Post-approval studies (Phase 4)Study completedNCT00211705What this trial is testingManagement of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese(MEGA Study)Who this might be right forHyperlipidemia Mitsukoshi Health and Welfare Foundation 8,000
Not applicableNot Yet RecruitingNCT06113939What this trial is testingPrevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion SuctioningWho this might be right forIntubation ComplicationStroke, IschemicStroke Hemorrhagic+4 more Hospital San Carlos, Madrid 60
Not applicableStudy completedNCT00843765What this trial is testingEfficiency Study of Traditional Chinese Medicine (TCM) Versus Western Medicine (WM) on Ischemic StrokeWho this might be right forStroke China Academy of Chinese Medical Sciences 1,151
Not applicableStudy completedNCT00660764What this trial is testingAssessment of the Efficacy of Rosuvastatin in Patient Groups With a Dissimilar Risk Profile in an Observational Study (HEROS)Who this might be right forHypercholesterolemiaCoronary Heart DiseasePeripheral Vascular Disease+2 more AstraZeneca
Testing effectiveness (Phase 2)Study completedNCT00938730What this trial is testingA Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial FibrillationWho this might be right forAtrial Fibrillation Astellas Pharma Inc 1,280
Not applicableStudy completedNCT01071408What this trial is testingTrial of a Secondary Stroke Prevention ProgramWho this might be right forIschemic StrokeTransient Ischemic Attack Sepulveda Research Corporation 54
Large-scale testing (Phase 3)Study completedNCT01225562What this trial is testingPrevention of Cardiovascular Events (eg, Death From Heart or Vascular Disease, Heart Attack, or Stroke) in Patients With Prior Heart Attack Using Ticagrelor Compared to Placebo on a Background of AspirinWho this might be right forMyocardial InfarctionCardiovascular DeathAtherothrombosis+1 more AstraZeneca 21,379
Not applicableLooking for participantsNCT03934957What this trial is testingHamburg City Health Study - a German Cohort StudyWho this might be right forCoronary Heart DiseaseStrokeDementia+7 more Universitätsklinikum Hamburg-Eppendorf 45,000
Large-scale testing (Phase 3)Study completedNCT00027066What this trial is testingWarfarin Versus Aspirin Recurrent Stroke StudyWho this might be right forStroke Columbia University 2,206
Large-scale testing (Phase 3)Study completedNCT01591018What this trial is testingSONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEryWho this might be right forCoronary Artery Bypass Graft RedoHeart Valve Diseases University Hospital Ostrava 120
Not applicableUnknownNCT05871528What this trial is testingRegistry of Patients With Remote Posterior cErebral Hemorrhage Following Reperfusion Treatment in Ischemic StrokeWho this might be right forIschemic StrokeIntracranial HemorrhagesHemorrhagic Transformation Stroke Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 250